Sara Magri
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors.
Journal: Frontiers in immunology
Published: June 08, 2023
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
Journal: International journal of cancer
Published: May 23, 2022
Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma.
Journal: Frontiers in oncology
Published: November 28, 2021
Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy.
Journal: Cancers
Published: November 09, 2021
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients.
Journal: Frontiers in immunology
Published: November 05, 2021
Correction to: Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors.
Journal: Immunity & ageing : I & A
Published: December 09, 2020
Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors.
Journal: Immunity & ageing : I & A
Published: June 30, 2020
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
Journal: Journal of nanobiotechnology
Published: December 09, 2019
The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.
Journal: Journal for immunotherapy of cancer
Published: December 24, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026